WUXI, China, Feb. 27, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has ...
Wuxi, a city located in East China's Jiangsu Province, by the shores of the Taihu Lake, has long been hailed as the "Pearl of Jiangnan Water Towns." It embodies the ideal image of a traditional ...
Furthermore, DMPK investigations and bioanalysis are essential to the ... and accredited by the AAALAC. • In January 2025, WuXi AppTec, a multinational corporation that offers a wide range of R&D and ...
Asia Pacific region is projected to grow at a solid CAGR of 10.9% during the forecast period. • The bioanalysis and DMPK studies segment is expanding at a CAGR of 8.5% from 2025 to 2034. • The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results